scholarly article | Q13442814 |
P356 | DOI | 10.1093/INFDIS/149.2.257 |
P698 | PubMed publication ID | 6421944 |
P2093 | author name string | Lerner AM | |
Reyes MP | |||
Tablan OC | |||
Rintelmann WF | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gentamicin | Q422482 |
P304 | page(s) | 257-263 | |
P577 | publication date | 1984-02-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis | |
P478 | volume | 149 |
Q28316869 | A comparison of netilmicin and tobramycin therapy in patients with renal impairment |
Q33714230 | Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials |
Q41148557 | Advances in medical and antibiotic management of infective endocarditis |
Q82519004 | Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex |
Q38676819 | Aminoglycoside-induced hearing loss in humans |
Q40423331 | Antibiotic therapy and the anesthesiologist |
Q98170152 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis |
Q33429288 | Antimicrobial therapy for pediatric patients |
Q46417990 | Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides |
Q50193219 | Drug-Induced Ototoxicity: Diagnosis and Monitoring. |
Q37687045 | Inhibition of ARC decreases the survival of HEI-OC-1 cells after neomycin damage in vitro |
Q40022701 | Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination |
Q34130045 | Monotherapy versus combination therapy for bacterial infections. |
Q35752292 | NaHS Protects Cochlear Hair Cells from Gentamicin-Induced Ototoxicity by Inhibiting the Mitochondrial Apoptosis Pathway |
Q54200566 | Piperacillin/tazobactam in the treatment of polymicrobial infections. |
Q40949882 | Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy |
Q35908254 | Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study |
Q38070006 | Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). |
Q28596353 | Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro |
Q35642347 | Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans |
Q40196347 | Serum level monitoring of antibacterial drugs. A review |
Q28361967 | Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides |
Search more.